WALTHAM, Mass., Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology-based therapies, today announced the appointment of Orlando Oliveira as its Chief Commercial Officer. With a career spanning nearly 25 years, Mr. Oliveira brings a wealth of experience building high-performing global commercial teams, driving revenue growth, and fostering strategic partnerships in the biotechnology and pharmaceutical industry. 'As we continue to advance multiple mid- to late-stage clinical development programs, we are thrilled to welcome Orlando to the Zenas leadership team,' said Joe Farmer, President and Chief Operating Officer. 'His expertise and track record of building and leading high performing commercial teams will be instrumental in the establishment of the obexelimab franchise and achievement of our goal to bring obexelimab to patients worldwide. We will benefit immensely from Orlando's broad commercial knowledge and leadership a s Zenas evolves to become an integrated development and commercial biopharmaceutical company.' Source: BERNAMA News Agency
Myanmar Confirms Nearly 309,000 Rohingya Eligible For Return Once Rakhine Security Improves
August 17, 2026
Naypyidaw: Myanmar has, for the first time, acknowledged that nearly 309,000 Rohingya refugees in Bangladesh as former residents of Rakhine state, saying they would be allowed to return once security